Director Robert S. Keane filed a Form 4 with the SEC on November 4, 2026, disclosing a conversion of 173,838 Class B shares of Astronics Corp into common stock on November 3, 2026, through Boston & Saranac LLC.
Barry Ticho, Chief Medical Officer of Stoke Therapeutics, Inc., filed a statement of changes in beneficial ownership on November 4, 2026, disclosing the sale of 7,195 shares of common stock on November 2, 2026.
Director Thomas N. Tryforos filed a Form 4 with the SEC on November 4, 2026, disclosing a purchase of 3,000 shares of Credit Acceptance Corp common stock on November 2, 2026, through TNT Investments LLC.
Kyle Andrew Raabe, President of Home Power Generation at Generac Holdings Inc., filed a Form 4 on November 4, 2026, disclosing stock option exercise and share sale transactions dated November 3, 2026, executed under a Rule 10b5-1(c) plan.
Lucid Group, Inc. director Ori Winitzer filed a Form 4 on November 4, 2026, disclosing the sale of 1,000 shares of Class A Common Stock on November 2, 2026, under a pre-established Rule 10b5-1 trading plan.
Patrick Fisher, President of Global Limb Recon at Orthofix Medical Inc., filed a Form 4 on November 4, 2026, disclosing a sale of 150 shares of common stock on November 2, 2026, under a pre-established Rule 10b5-1 trading plan.
Director Frances Arnold filed a Form 4 with the SEC on November 4, 2026, disclosing the sale of 11,409 shares of Generate Biomedicines, Inc. common stock on October 29, 2026, under a pre-established Rule 10b5-1 trading plan.
Michael Kliger, Chief Executive Officer of LuxExperience B.V. (NASDAQ:LUXE), filed a Form 4 on November 4, 2026, disclosing option exercises and open-market sales of ordinary shares on November 2 and November 3, 2026.
Director Fred E. Cohen filed a Form 4 with the SEC on November 4, 2026, disclosing a disposition of 25,000 shares of CareDx, Inc. common stock on November 3, 2026, via a gift transaction.
Director Susan H. Snow filed a Form 4 with the SEC on November 4, 2026, disclosing two acquisitions of NeoVolta Inc. common stock issued in connection with Board of Director services, held indirectly through The Susan Hegarty Snow Trust.